Bellerophon Therapeutics, Inc.·4

Sep 30, 4:53 PM ET

Shah Parag Suresh 4

4 · Bellerophon Therapeutics, Inc. · Filed Sep 30, 2019

Insider Transaction Report

Form 4
Period: 2019-09-26
Shah Parag Suresh
VP Proj Mgmt & Distribution
Transactions
  • Award

    Stock Option (right to buy)

    2019-09-26+175,500445,854 total
    Exercise: $0.50Exp: 2029-09-26Common Stock (175,500 underlying)
Footnotes (1)
  • [F1]1. This option was granted on September 26, 2019. This option vests in quarterly installments over a four-years period from the date of grant.

Documents

1 file
  • 4
    wf-form4_156987681297766.xmlPrimary

    FORM 4